Biopharmaceutical

Summary

Table of Contents

  • Publication date: March 2013
  • Report size: 25 pages
Keywords : Biopharmaceutical

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Schnell Biopharmaceuticals, Inc. SWOT Analysis report provides you a strategic analysis and detailed overview of the company’s businesses and operations. In this report, our analysts reveal t...

More »

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Talk to Alison

00 1 718 618 48 97

Send Your Request

Share

Biopharmaceutical Industry : Latest Reports

Accentia Biopharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Accentia Biopharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

Scil Biomedicals GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Scil Biomedicals GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

Navidea Biopharmaceuticals, Inc. (Formerly Neoprobe Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Navidea Biopharmaceuticals, Inc. (Formerly Neoprobe Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...


Biopharmaceutical Industry : Latest Downloads

MorphoSys AG - Company Report for Year 2012

MorphoSys AG - Company Report for Year 2012

  • Company report
  • November 2012
  • 19 pages

... Of going into even earlier- stage suffes. We also believe that gantenerumab has better properties than solanezumab, in that our antibody was deliberately made to bind and break down amyloid oligomers ...

Company Report: Bioprocessing for Year 2012

Company Report: Bioprocessing for Year 2012

  • Company report
  • October 2012
  • 4 pages

... Has yet to agree on definitions for both terms, which can have implications for risk mitigation and raw materials consistency in biopharmaceutical production. The panel will also address questions ...

Company Report: Biopharmaceutical for Year 2012

Company Report: Biopharmaceutical for Year 2012

  • Company report
  • October 2012
  • 32 pages

... Biomarin pharmaceutical inc. (Nasdaq: bmrn) is a multinational biopharmaceutical company that specializes in providing first-to-market therapeutics to patients with rare genetic diseases. Biomarin has ...


Related Market Segments :

Biopharmaceutical

Company Profiles

10 Companies

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.